Idiopathic aplastic anemia (AA) is a common cause of acquired bone marrow failure. Although autoimmunity to hematopoietic progenitors is thought to be responsible for its pathogenesis, little is known about the molecular basis of this autoimmunity. Here we show that a substantial proportion of AA patients harbors clonal hematopoiesis characterized by the presence of acquired copy number-neutral loss of heterozygosity (CNN-LOH) of the 6p arms (6pLOH). The 6pLOH commonly involved the human leukocyte antigen (HLA) locus, leading to loss of one HLA haplotype. Loss of HLA-A expression from multiple lineages of leukocytes was confirmed by flow cytometry in all 6pLOH(+) cases. Surprisingly, the missing HLA-alleles in 6pLOH(+) clones were conspicuously biased to particular alleles, including HLA-A*02:01, A*02:06, A*31:01, and B*40:02. A large scale epidemiological study on the HLA alleles of patients with various hematologic diseases revealed that the four HLA alleles were overrepresented in the germline of AA patients. These findings indicate that the 6pLOH(+) hematopoiesis found in AA
Introduction
Acquired aplastic anemia (AA) is a rare condition associated with bone marrow failure and pancytopenia 1 .
A series of classical observations and experiments have unequivocally supported that the auto-immunity to hematopoietic stem / progenitor cells (HSPCs) critically underlies the pathogenesis of the bone marrow failure in the majority of AA cases. According to the widely accepted model of immune-mediated bone marrow failure, activated cytotoxic T cells (CTLs) that recognize an auto-antigen(s) presented on HSPCs through their class I HLA molecules have a major role in initiating the autoimmune reactions 2-4 . However, no definitive evidence exists that supports this model or the presence of such CTL repertoires. Moreover, little information is available about their target antigens or about the way by which they are recognized by effector T cells.
Another long-standing issue on AA is its close relationship with clonal hematopoiesis 5, 6 . It was first suspected from an apparent overlap between AA and paroxysmal nocturnal hemoglobinuria (PNH) 7, 8 , and was also implicated by the frequent development of late clonal disorders in AA, such as myelodysplastic syndromes (MDS), PNH, or even acute myeloid leukemia (AML) [9] [10] [11] . Clonal hematopoiesis can be explicitly demonstrated by conventional clonality assays at presentation in a substantial proportion of newly diagnosed typical AA cases
12
. Although it has been expected that the inciting autoimmune insult somehow confers selective pressures on the evolution of clonal hematopoiesis 5 , the exact mechanism for such immunological selection or escape is still unclear.
The objectives of this study, therefore, were to characterize the clonal nature of the hematopoiesis that is maintained even under the severe autoimmune insult in AA, and to explore the genetic/immunologic mechanism that could underlie the pathogenesis of AA. To achieve these aims, we performed single nucleotide polymorphism (SNP) array-based analysis of genomic copy numbers and/or allelic imbalances in peripheral blood (PB) specimens obtained from 306 patients with AA. Initially, we found that AA patients frequently showed clonal/oligoclonal hematopoiesis that lost specific HLA alleles as a result of copy number-neutral loss of heterozygosity (CNN-LOH) of the 6p arms, which led us to further analyses of the contribution of 6pLOH(+) clones to residual hematopoiesis and a large scale epidemiological study on the For personal use only. on May 1, 2017. by guest www.bloodjournal.org From HLA alleles that are overrepresented in AA, involving a total of 6,613 transplants registered in the Japan Marrow Donor Program (JMDP).
Methods

Subjects
PB specimens from a total of 306 patients with AA were analyzed for the presence of genetic alterations using SNP arrays (see below). The clinical characteristics of these patients are summarized in Table 1 and   Supplementary Table 1 . Among the 306 patients, 107 were newly diagnosed while 199 were previously treated. Ninety-six patients received allogeneic bone marrow transplantation from unrelated donors through the JMDP, and their HLA information was available from the JMDP. The other 210 were newly genotyped for HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 alleles as described elsewhere 13 . 103 patients had been treated with anti-thymocyte globulin (ATG) plus cyclosporine (CsA), CsA alone, or anabolic steroids at the time of sampling. All patients and healthy individuals provided their informed consent before sampling in accordance with the Declaration of Helsinki. The study protocol was approved by the ethics committee of the Graduate School of Medical Science, Kanazawa University and also by that of the Graduate School of Medicine, University of Tokyo.
Analysis of genomic copy numbers and detection of 6pLOH
Genomic copy numbers, as well as allele-specific copy numbers, were analyzed by using GeneChip® 500K arrays (Affymetrix) as previously described 14, 15 . Briefly, genomic DNA from AA patients and normal controls were analyzed on GeneChip® 500K arrays separately. After adjusting several biases introduced during experiments, signal ratios of the corresponding probes between test (patient) and controls were calculated across the genome to obtain genome-wide copy numbers. Genetic lesions, including copy number gains and losses, as well as CNN-LOHs, were first detected using a hidden Markov model (HMM)-based algorithm implemented in the CNAG software 14, 15 . Known copy number variations were carefully excluded by referring to the Database of Genomic Variants (http://projects.tcag.ca/variation/).
For personal use only. on May 1, 2017. by guest www.bloodjournal.org From CNN-LOH in 6p involving the HLA locus was more specifically and sensitively detected by statistically evaluating the mean differences in allele-specific copy numbers between heterozygous SNPs on 6p (N=~1,400) that were telomeric from the 5' end of the HLA-A locus (rs1655927) and all non-6p heterozygous SNPs (N=~10,5000) using the Mann-Whitney's U test with the R package (http://www.r-project.org/). Possible false positive findings arising from multiple testing involving the 306 samples were evaluated by maintaining the false discovery rate (FDR) under 0.01 as previously described 16 , where the microarray data of 1,000 JMDP donor specimens obtained from an ongoing whole genome association study (unpublished data) were used to calculate an empiric null distribution 17, 18 .
Determination of the missing HLA alleles in 6pLOH(+) clones in patients with AA
The 500K SNP data of the 1,800 JMDP donor-recipient pairs (JMDP data set), together with their HLA genotyping information, was used to generate an HLA SNP haplotype table on the GeneChip® 500K platform, which contains the consensus SNPs of the three major haplotypes (P1, P2, and P3) in Japanese subjects 18 and the SNP sequences of all observed HLA haplotypes complementary to either of P1-P3 within the JMDP set (N = 1576) (data not shown). To determine the missing HLA haplotype in each 6pLOH(+) patient, those "HLA" haplotypes were first selected from the above HLA haplotype table that were compatible with the observed HLA genotypes of that patient. Among these, a candidate haplotype was selected such that it contained the minimum number of SNPs that were incompatible with the patient's genotype. For each candidate haplotype, genomic copy numbers were inferred at the heterozygous SNPs along that haplotype using the circular binary segmentation algorithm 19, 20 , which divided the haplotype into one or more discrete segments with different mean copy numbers. Finally, each copy number segment was thought to be 'missing', when the alternative hypothesis Ha : Figure. 1 ). Finally, for those HLA types that appeared more than 8 times among
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Flow cytometry
Heparinized PB and BM were collected from the patients at diagnosis and/or after treatment. HLA-A expression on granulocytes, monocytes, B and T cells, and BM CD34 + cells was analyzed by flow cytometry using a FACS Canto II® instrument (Beckton Dickinson) with the FlowJo program (Tree Star, Inc.). The monoclonal antibodies used for this study are provided in Supplementary Table 2 .
Human Androgen Receptor Assay (HUMARA)
The human androgen receptor gene was amplified from genomic DNA of 23 female patients including 3 6pLOH(+) patients, as described by Ishiyama et al. 21 with some modifications. Clonality was assessed using an "S value" as a marker of skewing in granulocytes and T lymphocytes.
Association of HLA types with AA
A total of 6,613 patients who had received allogeneic bone marrow transplantation through the JMDP between 1992 and 2008 were investigated to see whether the HLA alleles frequently missing in CNN-LOH in 6p with the development of AA could represent risk alleles for the development of AA. 
Results
Genetic lesions in AA detected by SNP array analysis
After excluding known or suspected copy number variations, a total of 50 genetic lesions were identified in 46 out of the 306 (15%) PB specimens of our AA case series (Table 1 and Figure. 1). Among these by far the most conspicuous was the recurrent CNN-LOH involving the 6p arm, which was detected in 28 cases as a significant dissociation of allele-specific copy number graphs in 6p regions using a hidden Markov model (HMM)-based algorithm implemented in the CNAG software 2,14,15 ( Figure. 2A and 2B). Of particular interest was that all CNN-LOH in 6p commonly affected the HLA locus, causing a haploid loss of HLA alleles and uniparental HLA expression. In some cases, the breakpoint of the 6pLOH was predicted to fall within the HLA locus ( Figure. 2B ). These findings strongly indicated that the HLA locus was the genetic target of these 6pLOHs. Also supporting this was the finding that in half of the cases, the dissociations in the allele-specific copy number graphs were gradually attenuated to the baseline over several mega base pair regions rather than showing a discrete breakpoint, indicating the presence of multiple 6pLOH(+) clones within a single case that had different breakpoints but still shared the same missing HLA alleles ( Figure. 2C). Moreover, the 6pUPDs existing only in a minor population were more sensitively detected by statistically evaluating the size of dissociation of allele-specific copy numbers in the 6p arm. With this improved statistical test, CNN-LOH in 6p was found in a total of 40 cases (13%) ( Figure. 2D and Supplementary Figure. 2), where the FDR was maintained at 0.01 to avoid too many false positive findings.
In all 6pLOH(+) cases, substantial numbers of heterozygous SNP calls were retained within the affected regions, thus indicating that the CNN-LOHs in 6p were not constitutional but represented acquired genetic events only found in the affected subclones ( Figure. 1 ). In fact, all 6pLOH(+) cases were shown to have 'heterozygous' HLA alleles in high-resolution HLA typing of their PB (Table 2 ). Moreover, 6pLOH was not detected in the CD3-positive T cells in selected cases (cases 25 and 26, Supplementary Figure. 3). By quantitatively comparing the observed differences in allele-specific copy numbers in the 6pLOH segments with what were expected assuming 100% LOH(+) components, the 6pLOH(+) clones were estimated to account for 0.2 % to 53.9 % of the PB leukocytes ( Table 2 ). The trend of the lower percentages of the 6pLOH(+) fraction in newly diagnosed patients compared to those in patients at remission was thought to
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The disease status of the 40 patients at the sampling was before treatment in 16 cases, during remission for 1-16 years after therapies in 15, and before bone marrow transplantation for refractory disease in 9. All evaluable 6pLOH(+) AA cases responded to immunosuppressive therapy (IST) (23/23), whereas 101 of 126 evaluable cases with 6pLOH(−) responded (P = 0.014) ( Table 3) .
Uniparental expression of HLA-A in multi-lineage hematopoietic cells
The genetic loss of one HLA haplotype in SNP array analysis was further confirmed by expression analysis Figure. 7 ). Together, these findings suggested that the 6pLOH involved early HSPCs, and that the 6pLOH occurred at the level of long-term repopulating stem cells.
Clonality of the HLA-missing granulocytes
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The HUMARA (Human Androgen Receptor)-based clonality assays in granulocytes were performed in 3 6pLOH(+) and 20 6pLOH(−) patients, in which all three 6pLOH(+) and 4 (20%) of the 6pLOH(−) patients showed evidence of clonality in granulocyte populations (Supplementary Figure. 8 ).
Missing HLA alleles in 6pLOH
Given that the HLA is the genetic target of 6pLOH in AA, the missing HLA alleles in 6pLOH are of particular interest, because in this context, they are thought to be directly involved in the presentation of the target auto-antigens to CTLs, and therefore, to be critically important in the pathogenesis of AA. We determined the missing HLA alleles in each 6pLOH(+) AA patient by the haplotype imputation of HLA alleles based on the large data of HLA haplotypes observed in the JMDP set, followed by statistical evaluation of allele-specific copy numbers along the imputed haplotypes ( Figure. Table 4 ).
Overrepresentation of frequently missing HLAs in AA populations
Because these missing HLA alleles in 6pLOH could be involved in the pathogenesis of AA, we next tested whether these relevant HLA alleles are associated with the risk of the development of AA among the 6,613 JMDP registrants. As shown in Table 4 , the 4 major missing HLA alleles, HLA-A*31:01, B*40:02, A*02:01 and A*02:06 were more frequently observed in AA cases compared to non-significant HLA alleles
For personal use only. on May 1, 2017. by guest www.bloodjournal.org From (i.e. all HLA alleles other than these 4 alleles), where the odds ratios for the risk of the development of AA between each of these alleles and non-significant alleles were 1.87 (95%CI; 1.43 -2.43) for A*02:01, 2.22 (95%CI; 1.70 -2.90) for A*02:06, 1.37 (95%CI; 1.00 -1.88) for A*31:01, and 1.95 (1.48 -2.58) for B*40:02 (Table 4 ). The combined relative risk for all these alleles was 1.75 (1.42 -2.17) (P = 1.3 x10 -7
).
Discussion
The origin of clonal hematopoiesis in AA is a focus of long-standing disputes, in which a profoundly reduced hematopoietic stem cell pool and/or escape from the autoimmune insults have been implicated in the evolution of the clonal hematopoiesis in AA 5, 22, 23 . Our findings on 6pLOH in AA provide an intriguing insight not only into the underlying mechanism of the clonal hematopoiesis in AA, but also into the origin of the autoimmunity that is responsible for the pathogenesis of AA. A recent study from the United States also reported three cases with 6pLOH 24 . With a sensitive detection algorithm, the presence of the 6pLOH(+) components was demonstrated in as many as 13% of typical cases with AA, and the evidence from the subsequent studies strongly indicated that the HLA genes are the genetic targets of 6pLOH in AA patients. First, the HLA locus was commonly and critically involved in all 6pLOHs found in AA. Second, some AA patients carried multiple 6pLOH(+) subclones with different breakpoints, but in all cases, the 6pLOH involved the HLA locus and occurred in a manner that targeted the same parental HLA allele. Moreover, particular class I HLA alleles were overrepresented among 6pLOH(+) cases and consistently found in the missing haplotypes. Finally, many of these HLA alleles were shown to be tightly associated with the development of AA in Japanese patients in case-control studies using the large JMDP registry.
The conspicuous bias of the missing HLA alleles in 6pLOH to particular HLA types, and the significant association of AA with those HLA types strongly suggest that the recurrent 6pLOH in AA is a phenomenon tightly related to the pathogenesis of AA rather than mere secondary event during the course of AA.
Based on these observations, it is well reasoned that in 6pLOH(+) AA cases, the auto-immunity to HSPCs is mediated by the CTLs that target the antigens presented via specific class I HLA molecules, and that the For personal use only. on May 1, 2017. by guest www.bloodjournal.org From 6pLOH(+) cells found in AA could be explained as escape hematopoiesis that survives the auto-immune insult by genetically deleting the relevant HLA species that are required for antigen presentation (Figure. In light of the above considerations, the chronological behavior of the 6pLOH(+) components in PB is also interesting and worth discussing. Despite the assumption that 6pLOH is an effective escape mechanism from CTLs, the 6pLOH(+) stem cells were unable to repopulate the BM to cure AA, unless effective IST was applied (Supplementary Figure. 6 ). This is most likely explained by the presence of inflammatory cytokines, such as IFN-γ and TNF-α, which have also been shown to play an important role in the bone marrow failure in AA, and are thought to be responsible for the continued prevention of the 6pLOH(+) stem cells from fully expanding and reconstituting the BM (Supplementary Figure. 9A and 9B) 27, 28 .
When the autoimmune insults are removed after IST, no further injury of normal stem cells would occur.
However, this does not necessarily mean the surviving normal stem cells can eventually outnumber the 6pLOH(+) stem cells over time. Note that once the autoimmune insults disappear, nothing could biologically or immunologically discriminate a 6pLOH(+) stem cell from a 6pLOH(−) stem cell (Supplementary Figure. 9A ). In particular, a 6pLOH(+) stem cell and a 6pLOH(−) stem cell will produce the same number of progeny on average, and feed the same number of mature blood cells. As a consequence, once established, the predominance of 6pLOH(+) stem cells over 6pLOH(−) stem cells should be maintained, after the severely reduced hematopoietic stem cell pool has been re-expanded with removal of the inciting autoimmunity. It is also of note that the recovery of myeloid components after IST, which are affected more strongly by 6pLOH than lymphoid cells, contributes to an apparent increase in 6pLOH components in the SNP array analysis in PB (Supplementary Figure. 6A ).
One of the most significant findings in the current study is the identification of the HLA alleles that are overrepresented in the Japanese AA populations, including HLA-A*31:01, B*40:02, A*02:01, and A*02:06.
All of these HLA alleles belong to class I major histocompatibility complexes (MHCs) and thus are thought to be involved in the antigen presentation to CTLs. This provides another prominent example, in which specific HLA-types play a critical role in the development of a human disease, and the information about these particular HLA types provides a solid basis on which we can ultimately isolate the relevant antigens responsible for the development of AA. Of particular note, there was a previous report that indicated that HLA-B*40:02 and A*02:06 were overrepresented in PNH as well as AA, although the study size was much smaller than the current study 29 . Combined with our study, these findings support the hypothesis that AA and PNH are the different outcomes of the same immunologic insult 5, 30 , and may also provide the genetic basis of the high prevalence of AA and PNH in East Asia 31, 32 In some AA cases, hematopoiesis could be maintained over years by the progenitors that escaped and survived the inciting autoimmune insult by deleting the target HLA through CNN-LOH in 6p. Given that the 6pLOH was detected in only 13 % of our series, it is likely that other escape mechanisms may also operate to maintain hematopoiesis in AA. In fact, clonality was clearly demonstrated in 20% of the 6pLOH(−) cases in the HUMARA study (Supplementary Figure. 8 ). In addition, our SNP array analysis also revealed a variety of clonal abnormalities in AA cases ( Figure. 1), although it is still open to question whether these abnormalities actually represent the mechanism of escape hematopoiesis or were related to some neoplastic process. Further studies on the genetic basis of the escape mechanisms would contribute to our understanding of the molecular pathogenesis of AA.
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